|Edwards Lifesciences Corporation -- USA Stock|| |
USD 120.49 3.42 2.76%
Corporate Vice President Japan, Asia Pacific
Dr. Huimin Wang M.D., is Corporationrationrate Vice President, Japan, Asia Pacific of Edwards Lifesciences Corporationrationration. From 2004 to 2010. Dr. Wang was Corporationrationrate Vice President, Japan, Asia and Pacific since 2010. Previously, he served in a number of roles with Baxter Healthcare Corporationrationration, including Senior Manager of Strategy Development, Director of ProductTherapy for the Renal Division in Japan, President of Medical Systems and Devices in Japan, and was a representative director of Baxter Limited, a Japan corporation, through September 2002. Before joining Baxter, Dr. Wang was a senior associate with Booz, Allen Hamilton in Chicago, Vice President of Integrated Strategies, a consulting and venture management firm he cofounded, and an associate with McKinsey Company. Dr. Wang is a Visiting Associate Professor of anesthesiology at Keio University
Age: 59 President Since 2010 MBA
949 250-2500 www.edwards.com
Wang earned his Doctor of Medicine degree from Kagoshima University in Japan and was a Resident and Staff Physician in anesthesiology at Keio University Hospital in Tokyo. He earned his MBA from the University of Chicago.
Huimin Wang Latest Insider Activity
The company has Return on Asset (ROA)
of 12.64 %
which means that for every $100 of asset it generated profit of $12.64. This is typical in the industry. Likewise, it shows return on total equity (ROE)
of 25.45 %
which means that it produced $25.45 on every 100 dollars invested by current stockholders.
The company reports 1.03 B of total liabilities with total debt to equity ratio (D/E) of 32.7 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Edwards Lifesciences Corporation has Current Ratio of 3.42 indicating that it is in good position to pay out its debt commitments in time.
Edwards Lifesciences Corporationration offer solutions and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences Corporation (EW) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 9,800 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification.